Biotricity, Inc. (BTCY)
- Previous Close
1.0600 - Open
1.0866 - Bid 1.0200 x 100
- Ask 1.1000 x 100
- Day's Range
1.0198 - 1.0866 - 52 Week Range
0.5510 - 3.7840 - Volume
19,763 - Avg. Volume
83,923 - Market Cap (intraday)
12.524M - Beta (5Y Monthly) 1.41
- PE Ratio (TTM)
-- - EPS (TTM)
-1.7500 - Earnings Date Jun 28, 2024 - Jul 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
www.biotricity.comRecent News: BTCY
Performance Overview: BTCY
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BTCY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BTCY
Valuation Measures
Market Cap
12.52M
Enterprise Value
36.06M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
--
Enterprise Value/Revenue
3.10
Enterprise Value/EBITDA
-3.76
Financial Highlights
Profitability and Income Statement
Profit Margin
-125.43%
Return on Assets (ttm)
-95.17%
Return on Equity (ttm)
--
Revenue (ttm)
11.63M
Net Income Avi to Common (ttm)
-15.39M
Diluted EPS (ttm)
-1.7500
Balance Sheet and Cash Flow
Total Cash (mrq)
309.99k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-35.57k